sciencenewsnet.in

Mount Sinai seeks EUA from Food and Drug Administration for potential quantitative serologic test for COVID-19

June 17, 2020 sarah Jonas Bio-Techne, Carlos Cordon-Cardo, Convalescent Plasma, Coronavirus, COVID-19, Emergency Use Authorization, Florian Krammer, Icahn School of Medicine at Mount Sinai, Infectious Disease, Kantaro Biosciences, Medicine, Microbiology, Mount Sinai Health System, Mount Sinai Innovation Partners, Nature Medicine, Science, U.S. Food And Drug Administration

If authorized for quantitative use, the assay could be used to provide a numeric result for the concentration of neutralizing anti-COVID-19 antibodies in plasma.